Activating BRAF mutations in papillary thyroid carcinomas have been linked to aberrant methylation of several tumor-suppressor genes, including TIMP3, SLC5A8, DAPK and RARβ2 [56,57]. The gene discussed is BRAF; the disease is differentiated thyroid carcinoma.